Delivery Order SPE2DB22D1017-SPE2DB25FYSFZ
Award Date 9/29/25
Potential Completion Date 9/30/25
Potential Value $166K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies on September 16, 2025, with an ultimate completion date of September 17, 2025. The order, valued at $8,494.44 under a firm fixed-price contract type, covers 90 tablets of Myrbetriq ER 50 mg, a medication used to treat overactive bladder. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $11,783.17 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 and extends through December 2026....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $36,113.23 on July 29, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by July 30, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) valued at $10,626.75. This is a firm fixed-price delivery order with no set-aside designation, meaning the award was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This delivery order is issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 10, 2025, for Myrbetriq ER 50 mg tablets (90-count supply). The contract is valued at $22,567.53 with a firm fixed price structure and an ultimate completion date of September 11, 2025. This is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's existing Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $1,148.28. This firm fixed-price delivery order is non-set-aside and represents a competitively awarded pharmaceutical procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Myrbetriq ER 25 mg tablets (30-count units) valued at $1,549.42. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award to the pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. This...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $116,508.27. This firm fixed-price delivery order represents a non-set-aside competitive award and is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 through December...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) at a ceiling value of $1,769.79. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 23, 2025, with performance at the contractor's headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's competitive...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $18,202.77, is for the delivery of Myrbetriq ER 50 mg tablets. This delivery order is issued under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to...